Jul 18 |
Insiders At Amgen Sold US$6.5m In Stock, Alluding To Potential Weakness
|
Jul 16 |
3 Biotech Stocks to Buy Now: Q3 Edition
|
Jul 15 |
A Closer Look at Amgen's Options Market Dynamics
|
Jul 15 |
Will Amgen (AMGN) Beat Estimates Again in Its Next Earnings Report?
|
Jul 15 |
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
|
Jul 15 |
What Is the Dividend Payout for Amgen Stock?
|
Jul 14 |
3 Dividend Growth Stocks to Buy and Hold
|
Jul 13 |
Morgan Stanley sees $180B patent cliff, $380B deal capacity fueling biopharma M&A
|
Jul 13 |
Amgen Inc.'s (NASDAQ:AMGN) high institutional ownership speaks for itself as stock continues to impress, up 6.4% over last week
|
Jul 12 |
Amgen (AMGN) Rises Higher Than Market: Key Facts
|